Skip to content

Coronary Angiography Before Elective Carotid Endarterectomy in Patients With Asymptomatic Coronary Artery Disease

Randomized Controlled Trial Analyzing the Role of Systematic Preoperative Coronary Angiography Before Elective Carotid Endarterectomy in Patients With Asymptomatic Coronary Artery Disease

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02260453
Acronym
CACEA
Enrollment
426
Registered
2014-10-09
Start date
2005-01-31
Completion date
2012-06-30
Last updated
2014-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Stenosis, Coronary Stenosis

Brief summary

The purpose of this study is to evaluate the potential benefit of systematic preoperative coronary angiography followed by selective coronary artery revascularization on the incidence of myocardial infarction (MI) in patients without a history of coronary artery disease (CAD) and undergoing carotid endarterectomy (CEA).

Detailed description

Patients candidates for CEA, with no history of CAD, a normal electrocardiogram (ECG), and a normal cardiac ultrasound were randomized in two groups. In group A (n = 216) all patients underwent coronary angiography before CEA +- coronary artery revascularization. In group B (n = 210) CEA was performed without coronary angiography.

Interventions

OTHERPreoperative coronary angiography

If coronary disease is detected percutaneous intervention (PCI) or coronary artery bypass grafting (CABG) is applied

OTHERStandard cardiac workup

EKG, transthoracic cardiac echocardiogram

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* indication for carotid endarterectomy * no clinical sign or history of ischemic heart disease * no electrical signs of cardiac ischemia * left ventricular ejection fraction \>50% at transthoracic echocardiogram.

Exclusion criteria

* disabling stroke (mRS ≥3) * non atherosclerotic carotid disease * severe intracranial carotid artery stenosis * contra-indications to heparin, aspirin or clopidogrel.

Design outcomes

Primary

MeasureTime frame
Non-fatal and fatal myocardial infarction30 days through year 3

Secondary

MeasureTime frame
All-cause and cardiovascular mortality30 days through year 3

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026